Flumedroxone
Clinical data | |
---|---|
ATC code | N02CB01 (WHO) |
Identifiers | |
| |
Synonyms |
(6S,10R,13S,17S)-17-acetyl-17-hydroxy-10,13-dimethyl-6-(trifluoromethyl)-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one 17-Acetyloxy-6α-(trifluoromethyl)preg-4-ene-3,20-dione |
CAS Number | 987-18-8 |
PubChem (CID) | 71881 |
ChemSpider | 16736667 |
UNII | K80185F39X |
ChEMBL | CHEMBL2104932 |
Chemical and physical data | |
Formula | C22H29F3O3 |
Molar mass | 398.459 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(verify) |
Flumedroxone is a corticosteroid derivative used to treat migraines. In one study, the benefit was largely limited to women with headache associated with premenstrual syndrome.[1]
References
- ↑ Bradley WG, Hudgson P, Foster JB, Newell DJ (August 1968). "Double-blind controlled trial of a micronized preparation of flumedroxone (Demigran) in prophylaxis of migraine". Br Med J. 3 (5617): 531–3. doi:10.1136/bmj.3.5617.531. PMC 1986487. PMID 4877801.
This article is issued from Wikipedia - version of the 5/27/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.